Gabawa, Rosalie B.

HRN: 29-50-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2026
CEFTAZIDIME 1GM (VIAL)
08/20/2026
08/27/2026
IVT
2g
Q8
CAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: